Experimental drug trial seeks to improve treatment for head and neck cancer

A trial to test an experimental drug in patients with head and neck cancer has launched in the UK, through the Combinations Alliance – a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) Network. Researchers want to find out whether using Astra Zeneca’s AZD1775 experimental compound, in combination with chemotherapy before surgery or with chemotherapy and radiotherapy after surgery, is more effective and reduces the risk of the cancer returning.
Medical Xpress